A Phase II Study of Pemetrexed in chemo-naive Elderly Patients with Lung Adenocarcinoma and An exploratory study on Mechanisms of chemotherapy resistance.
Phase 2
- Conditions
- Previously untreated lung adenocarcinoma
- Registration Number
- JPRN-UMIN000006113
- Lead Sponsor
- Division of Respirology, department of internal medicine, Jikei University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1. Symptomatic brain metastasis 2. Massive pleural effusion 3. Hystory of active double cancer 4. History of uncontrollable diabetes mellitus, active angina pectoris, recent myocardial infaction, and severe complications 5. History of active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method one year survival rate
- Secondary Outcome Measures
Name Time Method overall survival, progression-free survival, objective response rate, adverse effects.